Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126884521 | 12688452 | 1 | I | 20160627 | 20160826 | 20160826 | PER | US-STRIDES ARCOLAB LIMITED-2016SP008852 | STRIDES | HITTI J, FRENKEL LM, STEK AM, NACHMAN SA, BAKER D, GONZALEZ-GARCIA A, PROVISOR A, THORPE EM, PAUL ME, FOCA M, GANDIA J, HUANG S, WEI LJ, STEVENS LM, WATTS DH, MCNAMARA J;. PACTG 1022 STUDY TEAM. MATERNAL TOXICITY WITH CONTINUOUS NEVIRAPINE IN PREGNANCY: RESULTS FROM PACTG 1022. J ACQUIR IMMUNE DEFIC SYNDR. 2004;36(3):772-6 | 0.00 | Y | 0.00000 | 20160826 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126884521 | 12688452 | 1 | PS | Lamivudine and Zidovudine Tablets | LAMIVUDINEIDOVUDINE | 1 | BID | U | U | 79128 | |||||||||
126884521 | 12688452 | 2 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | 200 MG ONCE DAILY | U | U | 0 | 200 | MG | |||||||
126884521 | 12688452 | 3 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | 200 MG, BID | U | U | 0 | 200 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126884521 | 12688452 | 1 | HIV infection |
126884521 | 12688452 | 2 | HIV infection |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126884521 | 12688452 | Exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |